BD Advances Iliac Artery Treatment Across the European Union
Becton, Dickinson and Company (BDX)
Last becton, dickinson and company earnings: 2/6 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bd.com
Company Research
Source: PR Newswire
FRANKLIN LAKES, N.J., March 5, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has obtained CE Marking for the Revello™ Vascular Covered Stent, a next-generation endovascular solution for the treatment of atherosclerotic lesions in the common and external iliac arteries. This advancement arrives at a pivotal moment, as lower-extremity peripheral artery disease (PAD), which iliac artery disease is a key component—drives a substantial disability burden across the EU's aging population.1,2 The Revello™ Vascular Covered Stent is designed to combine the flexibility of a nitinol self-expanding stent with the radial resistive force tailored for the iliac arteries."The CE Marking of the Revello™ Stent is a significant advancement towards helping physicians treating complex iliac artery disease," said Rima Alameddine, worldwide president, BD Interventional – Peripheral Intervention. "The Revello™ Vascular Cove
Show less
Read more
Impact Snapshot
Event Time:
BDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDX alerts
High impacting Becton, Dickinson and Company news events
Weekly update
A roundup of the hottest topics
BDX
News
- Blood Collection Devices (Tubes, Needles & Syringes, Blood Bags, Monitors) Market - Global Forecast to 2030 [Yahoo! Finance]Yahoo! Finance
- Mursla Bio Accelerates US Commercial Deployment of EvoLiver Through ABHI Programme [Yahoo! Finance]Yahoo! Finance
- BD Surgiphor Clearance Puts Surgical Consumables And Valuation In Focus [Yahoo! Finance]Yahoo! Finance
- BD Pioneers New Standard in Surgical Safety with FDA-Cleared Surgiphor™ 1000mL for Wound Irrigation [Yahoo! Finance]Yahoo! Finance
- BD Pioneers New Standard in Surgical Safety with FDA-Cleared Surgiphor™ 1000mL for Wound IrrigationPR Newswire
BDX
Earnings
- 2/9/26 - Beat
BDX
Sec Filings
- 3/4/26 - Form 4
- 3/4/26 - Form 4
- 2/27/26 - Form 4
- BDX's page on the SEC website